Maury Raycroft

Q: What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of 90.34089768919098.

Q: What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of 49.85537714964799.

Jefferies | Healthcare

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector. Ranked #275 out of 4655 analysts, they have issued 14 stock ratings with a success rate of 90.34% and an average return of 49.86%.

With 14 ratings to date, Maury Raycroft is beginning to establish credibility in the Healthcare sector. They have achieved a success rate of 90.34% and an average return of 49.86%, highlighting promising potential as their track record develops further.

#275

Out of 4655

Total Ratings

+90.34%

Success Rate

+49.86%

Average Return

Recent Ratings Analysis

TNGX

Hold

May 14, 2026

Target

$27.00

Current

$24.87

Performance

0.00%

Maury Raycroft rated TNGX as Hold on May 14, 2026, setting a price target of 27. The Hold stance appears justified, as shares hovered around 24.87 with a 0.00% move.

CRBP

Buy

May 13, 2026

Target

$33.00

Current

$11.98

Performance

-1.40%

On May 13, 2026, CRBP was given a Buy rating by Maury Raycroft, with a target price of 33. The stock traded sideways with a -1.40% move, keeping the bullish thesis unresolved.

TYRA

Buy

Feb 03, 2026

Target

$43.00

Current

$36.51

Performance

16.87%

TYRA received a Buy rating from Maury Raycroft on Feb 03, 2026, aiming for 43. Momentum has favored the Buy call, with shares climbing from 36.51 to 36.51, rewarding those who trusted the recommendation.

DNTH

Buy

Feb 02, 2026

Target

$81.00

Current

$85.34

Performance

60.47%

On Feb 02, 2026, Maury Raycroft published a Buy outlook on DNTH, with a target of 81. Shares gained 60.47%, underscoring the accuracy of the bullish outlook toward 81.

RARE

Buy

Dec 30, 2025

Target

$114.00

Current

$25.80

Performance

13.26%

Maury Raycroft on Dec 30, 2025 assigned RARE a Buy rating, with a price target of 114. The Buy call aligned well with market performance, producing a gain of 13.26%.

MREO

Hold

Dec 30, 2025

Target

$7.00

Current

$0.25

Performance

-33.60%

On Dec 30, 2025, Maury Raycroft reaffirmed MREO with a Hold rating, targeting 7. The Hold stance reflected market caution that was later justified.

CELC

Buy

Dec 02, 2025

Target

$134.00

Current

$134.72

Performance

38.17%

CELC was rated Buy by Maury Raycroft on Dec 02, 2025, with a price objective of 134. A bullish response from the market helped close the gap of -0.72 to the target.

AUPH

Buy

Nov 07, 2025

Target

$21.00

Current

$15.84

Performance

8.42%

On Nov 07, 2025, Maury Raycroft initiated coverage on AUPH with a Buy rating and target of 21. The stock’s climb of 8.42% since the call highlights the foresight in the rating.

OPK

Hold

Oct 31, 2025

Target

$1.60

Current

$1.10

Performance

-19.12%

Maury Raycroft issued a Hold recommendation for OPK on Oct 31, 2025, price target set at 1.6. Market action validated the conservative Hold outlook with shares at 1.1.

ALNY

Buy

Oct 30, 2025

Target

$549.00

Current

$293.45

Performance

-34.73%

On Oct 30, 2025, ALNY was evaluated by Maury Raycroft, who gave a Buy rating and target of 549. Investors saw limited payoff as shares fell short of the 549 target.

KZR

Hold

Oct 17, 2025

Target

$7.00

Current

$7.29

Performance

14.62%

Maury Raycroft rated KZR as Hold on Oct 17, 2025, setting a price target of 7. Despite the Hold call, shares climbed 14.62% to 7.29, revealing unexpected momentum.

KOD

Buy

Sep 22, 2025

Target

$15.00

Current

$38.70

Performance

157.83%

On Sep 22, 2025, KOD was given a Buy rating by Maury Raycroft, with a target price of 15. The stock rallied 157.83% after the rating, narrowing the gap to the target of 15 and validating the bullish stance.

CRDF

Hold

Jun 24, 2025

Target

$3.50

Current

$1.73

Performance

-45.94%

CRDF received a Hold rating from Maury Raycroft on Jun 24, 2025, aiming for 3.5. The Hold stance proved prudent, with the market softening by 45.94%.

CMRX

Hold

Mar 05, 2025

Target

$8.50

Current

$8.54

Performance

0.95%

On Mar 05, 2025, Maury Raycroft published a Hold outlook on CMRX, with a target of 8.5. Sideways action left the Hold view intact, with no major move since 8.54.

CMPX

Buy

Feb 10, 2025

Target

$8.00

Current

$1.98

Performance

-49.23%

Maury Raycroft on Feb 10, 2025 assigned CMPX a Buy rating, with a price target of 8. The call has struggled to gain traction, with shares losing 49.23%.

SGMO

Buy

Dec 31, 2024

Target

$3.00

Current

$0.13

Performance

-86.93%

On Dec 31, 2024, Maury Raycroft reaffirmed SGMO with a Buy rating, targeting 3. Shares slid 86.93% despite the recommendation, highlighting downside risks.

ERAS

Buy

Nov 18, 2024

Target

$6.00

Current

$10.37

Performance

279.85%

ERAS was rated Buy by Maury Raycroft on Nov 18, 2024, with a price objective of 6. A bullish response from the market helped close the gap of -4.37 to the target.

CALT

Hold

May 28, 2024

Target

$39.00

Current

$40.00

Performance

5.40%

On May 28, 2024, Maury Raycroft initiated coverage on CALT with a Hold rating and target of 39. The Hold stance underestimated the stock’s strength as it gained 5.40%.

PRME

Buy

May 07, 2024

Target

$15.00

Current

$3.13

Performance

-43.81%

Maury Raycroft issued a Buy recommendation for PRME on May 07, 2024, price target set at 15. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

Frequency Asked Questions

Who is Maury Raycroft?

Maury Raycroft is an analyst from Jefferies specializing in the Healthcare sector.

What is Maury Raycroft's success rate?

Maury Raycroft currently has a success rate of +90.34%.

How many ratings has Maury Raycroft issued?

Maury Raycroft has issued 14 stock ratings so far.

What is the average return of Maury Raycroft's calls?

Their stock ratings have generated an average return of +49.86%.

What is Maury Raycroft's ranking?

Maury Raycroft is ranked #275 out of 4655 analysts.

What types of ratings does Maury Raycroft give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Maury Raycroft?

You can follow Maury Raycroft by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Maury Raycroft?

Their latest rating was a Hold on TNGX issued on 2026-05-14.